Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: FDA

LifeSignals receives FDA 510 (k) Approval for LifeSignals LX1550 Multiparameter Remote Monitoring Platform


FREMONT, Calif., July 27, 2021 /CNW/ -- LifeSignals Inc., today announced it has received FDA Class II 510 (k) approval for the LifeSignals LX1550 Multiparameter Remote Monitoring Platform. This follows recent CE marking and is further validation of LifeSignals' drive to create innovative wireless platforms which can be used by clinicians for the continuous collection of patient physiological data at home and in healthcare settings.

Central to the platform is a single-use wearable multiparameter biosensor that records Electrocardiography (2-channel ECG), Heart Rate, Respiration Rate, Skin Temperature and Body Posture data for up to five days. The encrypted physiological data can then be transmitted with high reliability from the biosensor, via a relay app to a secure cloud-based platform. Clinicians and Care Providers can access the cloud-based remote monitoring dashboard to view patient physiological data and manage alert settings.

The Remote Monitoring Platform is designed to enable healthtech companies to rapidly enhance their product and service portfolios to provide vital sign monitoring to the widest possible patient base, from any location. The relay app and dashboard are developer-friendly with ready-to-deploy software development kit APIs and is suitable for large scale implementation.

"COVID-19 has broken down the barriers to remote patient monitoring globally and I am proud of how the LifeSignals team has responded to develop the Platform in such a short space of time," says Surendar Magar, Founder and CEO. "This FDA 510 (k) approval marks another major milestone in the company's development and mission. It has already been implemented successfully in hospitals for monitoring COVID-19 patients in India and is being rolled out in Europe, UK, Singapore and the Philippines. Our focus now is to rapidly introduce low-cost remote vital sign monitoring to US healthtech companies looking to expand their services and improve patient care."

www.lifesignals.com

Photo - https://mma.prnewswire.com/media/1582121/LifeSignals.jpg

 

SOURCE LifeSignals Inc


These press releases may also interest you

at 16:20
ICON plc , a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the first quarter ended March 31, 2024. CEO, Dr. Steve Cutler commented, "ICON reported a strong start to the year in...

at 16:20
Airgain, Inc. , a leading provider of wireless connectivity solutions that creates and delivers embedded components, external antennas, and integrated systems across the globe, will hold a conference call on Wednesday, May 8, 2024 at 5:00 p.m....

at 16:20
Tyler Technologies, Inc. , a large-cap growth technology company, today announced financial results for the first quarter ended March 31, 2024. The company's earnings release can be accessed via the News section of Tyler's investor relations website...

at 16:17
The Coalition for Food Security (CFS), led by minority-owned AgTech start-up, Ponix, is implementing a $5 million United States Department of Agriculture (USDA) grant, as part of the Partnerships for Climate-Smart Commodities program, which helps...

at 16:15
Forge Global Holdings, Inc. ("Forge") , a leading provider of marketplace infrastructure, data services and technology solutions for private market participants, today announced that it will report First Quarter Fiscal Year 2024 financial results on...

at 16:15
ServiceNow , the leading digital workflow company making the world work better for everyone, today announced financial results for its first quarter ended March 31, 2024, with subscription revenues of $2,523 million in Q1 2024, representing 25%...



News published on and distributed by: